Latest KROS reports update at 2024-05-08: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Keros Therapeutics
  4. Financial Ratios
  5. EV/EBITDA Ratio
Keros Therapeutics logo
Keros Therapeutics KROS
$ 57.6 -1.1%
mail-toReport an Error

Keros Therapeutics EV/EBITDA Ratio 2011-2024 | KROS

Annual EV/EBITDA Ratio Keros Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-20.3 -21.4 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-20.3 -21.4 -20.8